Loading...
XTAE
CBI
Market cap15mUSD
Dec 03, Last price  
33.80ILS
1D
6.62%
1Q
5.63%
Jan 2017
-85.95%
IPO
-96.69%
Name

Clal Biotechnology Industries Ltd

Chart & Performance

D1W1MN
No data to show
P/E
—
P/S
509.75
EPS
—
Div Yield, %
—
Shrs. gr., 5y
-0.21%
Rev. gr., 5y
-61.79%
Revenues
104k
-71.89%
1,404,0002,062,0001,339,0003,182,0004,745,0003,545,0009,067,0007,671,0003,452,00023,899,00025,417,00024,183,00043,461,00012,767,000113,293,00074,544,00076,961,000370,000104,000
Net income
-31m
L-49.71%
-57,137,000-15,442,000-44,557,000-83,042,00065,425,000350,868,00087,333,000-93,554,000-151,602,000-367,635,000-118,462,000-213,820,000-27,893,000-44,942,000-154,112,000109,027,000-89,583,000-61,740,000-31,051,000
CFO
-6m
L-23.90%
-17,434,000-23,549,000-47,049,000-52,415,000-86,860,000-111,926,000-102,451,000-81,222,000-148,976,000-115,952,000-146,999,000-112,633,000-91,405,000-86,981,00027,029,000-33,226,000-41,327,000-59,037,000-8,513,000-6,478,000
Dividend
Mar 29, 202122.3722 ILS/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Clal Biotechnology Industries Ltd. is a private equity and venture capital firm specializing in development stage, pre-clinical; incubation, seed, start-up, early venture, emerging growth, mid venture, late venture, PIPEs, and growth capital stages of financing. It prefers to invest in life sciences, medical devices, biopharmaceutical technologies, and biotechnology companies. The firm seeks to invest in companies based in United States, and Israel. It invests between $0.5 million and $10 million per company. It takes a seat on the board of directors of the companies it invests in. It invests through personal capital of its management. The firm acts as a lead investor and major shareholder in its portfolio companies. Clal Biotechnology Industries Ltd. was founded in July, 1998 and is based in Tel Aviv, Israel with an additional office in Cambridge, Massachusetts. It operates as a former subsidiary of Clal Industries and Investments Ltd.
URL
https://www.cbi.co.il/
IPO date
May 30, 2007
Employees
Domiciled in
IL
Incorporated in
IL

Valuation

Title
ILS in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT